161 results
8-K
EX-3.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
it simultaneously complies with the previous sentence.
4. Voting Rights.
4.1 Except as otherwise provided herein or as otherwise required by the DGCL … , the Series A Non-Voting Preferred Stock shall have no voting rights. However, as long as any shares of Series A Non-Voting Preferred Stock are outstanding
8-K
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
as dividends actually paid on shares of the Common Stock. Except as otherwise required by law, the Series A Preferred Stock does not have voting … rights. However, as long as any shares of Series A Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders
8-K
EX-3.5
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
authorized to fix or alter the dividend rights, dividend rate, conversion rights, voting rights, rights and terms of redemption (including sinking fund … of a majority of the voting rights of all classes of stock entitled to vote, provided, however, that no amendment, alteration, change or repeal
8-K
EX-10.10
06j9dvod7woius 2w
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.5
9rhbo b5cnmn2kimc1pb
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-3.6
6qu57antt nk3j
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-3.9
q1sjog20ff0c
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
424B3
syejulizrcjkc3s24r
1 Aug 24
Prospectus supplement
4:10pm
425
nq6zm
3 Apr 24
Business combination disclosure
7:33am
8-K
435 d1soqzc6rx
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
EX-3.1
nw33 cqv3oh48wehhoo
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am